Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18449799 | 0.88 | PREP (0.40) | PREPNR1H2 | |
| SCHEMBL22032691 | 0.82 | — | — | |
| SCHEMBL22032965 | 0.82 | — | — | |
| SCHEMBL22032693 | 0.82 | — | — | |
| SCHEMBL1219788 | 0.80 | CHRM2 (0.32) | — | |
| SCHEMBL30242513 | 0.75 | PREP (0.39) | PREPNR1H2 | |
| SCHEMBL30242481 | 0.75 | PREP (0.39) | PREPNR1H2 | |
| SCHEMBL22032728 | 0.75 | PREP (0.39) | PREPNR1H2 | |
| SCHEMBL1220564 | 0.73 | — | — | |
| SCHEMBL17049887 | 0.73 | PREP (0.42) | PREPNR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3347350-A1 | HETEROCYCLIC CONSTRAINED TRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS | Icahn School of Medicine at Mount Sinai (US) | 2018-07-18 | — | — | EP | disclosed |
| WO-2017044567-A1 | HETEROCYCLIC CONSTRAINED TRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2017-03-16 | — | — | WO | disclosed |